Gaps in ambulatory patient safety for immunosuppressive specialty medications.
Patterson S, Schmajuk G, Evans M, et al. Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications. Jt Comm J Qual Patient Saf. 2019;45(5):348-357. doi:10.1016/j.jcjq.2018.12.003.
This retrospective cohort study sought to determine whether screening for tuberculosis and hepatitis B and C was consistently performed prior to initiating immunosuppressive medications. About a quarter of patients were appropriately screened for all three infections before starting these high-risk medications, demonstrating the need for safety protocols regarding provision of immunosuppressive medication.